Liberty Biopharma announces $10M prospectus offering
Liberty Biopharma has engaged Kernaghan & Partners for a “best efforts” offering of up to $10MContinue Reading
Liberty Biopharma has engaged Kernaghan & Partners for a “best efforts” offering of up to $10MContinue Reading
DW Healthcare Partners Fund IV final closed at US $295M. Credit Suisse Securities (USA) acted as placement agent.Continue Reading
RockGarden Medicinals, intends to issue shares representing 25% of total shareholding for gross proceeds of $1.53M.
Continue Reading
LightIntegra Technology appointed William “Bill” Dubiel as new President & CEO and a director. Continue Reading
Resolve Digital Health, a developer of smart inhaler tracking medical cannabis, has closed a private financing.
Continue Reading
Ventripoint Diagnostics closed $3.36M private placement with existing shareholders and new subscribersContinue Reading
Peter J. Thomson’s Structured Alpha invests additional $25M in Prometic Life Sciences, bringing total loan investment to $85M. Continue Reading
Mauricio Domenzain in partnership with Nexxus Capital to take Immunotec for $34.3MContinue Reading
Canopy Growth closed $24.25M financing with one unnamed investor. Goldman Holdings agrees to lend free-trading shares to the investor.Continue Reading
Winston Resources closed oversubscribed non-brokered private placement for $2.9MContinue Reading
Fight Against Cancer Innovation Trust announced a seed investment in Propellon Therapeutics.Continue Reading
Prevtec Microbia raised $2.5M from Telesystem Ltd., Desjardins-Innovatech, S.E.C., Grupo Corporativo Fuertes, S.L., Echo Capital FIER Outaouais, s.e.c.Continue Reading
Fight Against Cancer Innovation Trust launches evergreen Prospects Oncology Fund for early-stage Ontario cancer discoveriesContinue Reading
Aurinia Pharmaceuticals completed previously announced public offering for gross proceeds of US $173MContinue Reading
CVR Medical to close an institutionally led non-brokered private placement for up to $5 million.Continue Reading
BELLUS Health to sell Thallion Pharmaceuticals and the drug candidate Shigamab to Taro for up to $2.7 million.Continue Reading
Titan Medical closed $7.5M offering led by Bloom Burton Securities with Roth Capital Partners acting as special selling group member.Continue Reading
© 2023 CPE News, a division of CPE Media & Data Company. All Rights Reserved. 500-245 Fairview Mall Drive, Toronto, Ontario M2J 4T1 | 647-872-6300